ViacomCBS soars after Q1 earnings beat Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Moderna (MRNA) up 16% after announcing that the FDA completed its review of the company's investigational new drug application for its novel coronavirus vaccine candidate, mRNA-1273, allowing it to proceed to Phase 2 study
- Evelo Biosciences (EVLO) up 25% after announcing the submission of an investigational new drug application for an Evelo-sponsored Phase 2 clinical study evaluating the safety and efficacy of EDP1815 for the treatment of hospitalized patients with newly diagnosed COVID-19
UP AFTER EARNINGS -
- Bristol Meyers (BMY) up 2%
- Raytheon Technologies (RTX) up 5%
- AB InBev (BUD) up 3%
- Hilton (HLT) up 5%
- ViacomCBS (VIAC) up 17%
- CommScope (COMM) up 2%
- Vonage (VG) up 8%
- Twilio (TWLO) up 25%
DOWN AFTER EARNINGS -
- Elanco (ELAN) down 6%
- JetBlue (JBLU) down 1%
- Briggs & Stratton (BGG) down 17%
- Spirit Airlines (SAVE) down 15%
- Etsy (ETSY) down 5%
- National Vision (EYE) down 9%
ALSO LOWER -
- Vapotherm (VAPO) down 6% after 3.35M share spot secondary priced at $26.00
Symbols:
MRNA EVLO BMY RTX BUD HLT VIAC COMM VG ELAN JBLU SAVE ETSY EYE VAPO Keywords: Fly Intel, Wall Street, Top Stories, Stocks